Shanxi C&Y Pharmaceutical Group Co Ltd (300254) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.092x

Based on the latest financial reports, Shanxi C&Y Pharmaceutical Group Co Ltd (300254) has a cash flow conversion efficiency ratio of 0.092x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥52.93 Million ≈ $7.75 Million USD) by net assets (CN¥577.09 Million ≈ $84.45 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Shanxi C&Y Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2008–2024)

This chart illustrates how Shanxi C&Y Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Shanxi C&Y Pharmaceutical Group Co Ltd for a breakdown of total debt and financial obligations.

Shanxi C&Y Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanxi C&Y Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Fenix Outdoor International AG ST:FOI-B	0.140x
Dada Nexus Ltd NASDAQ:DADA	0.009x
Shenzhen Liantronics SHE:300269	0.097x
Alexander Forbes Grp Hldg Ltd JSE:AFH	0.770x
Ningbo Tianyi Medical Appliance Co. Ltd. SHE:301097	N/A
ScinoPharm Taiwan Ltd TW:1789	0.033x
Yulon Nissan Motor Co Ltd TW:2227	-0.007x
Grand Korea Leisure Co. Ltd KO:114090	0.076x

Annual Cash Flow Conversion Efficiency for Shanxi C&Y Pharmaceutical Group Co Ltd (2008–2024)

The table below shows the annual cash flow conversion efficiency of Shanxi C&Y Pharmaceutical Group Co Ltd from 2008 to 2024. For the full company profile with market capitalisation and key ratios, see Shanxi C&Y Pharmaceutical Group Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥598.18 Million ≈ $87.53 Million	CN¥70.94 Million ≈ $10.38 Million	0.119x	+144.13%
2023-12-31	CN¥778.43 Million ≈ $113.91 Million	CN¥37.81 Million ≈ $5.53 Million	0.049x	-52.66%
2022-12-31	CN¥729.68 Million ≈ $106.78 Million	CN¥74.88 Million ≈ $10.96 Million	0.103x	-21.17%
2021-12-31	CN¥744.58 Million ≈ $108.96 Million	CN¥96.92 Million ≈ $14.18 Million	0.130x	+644.07%
2020-12-31	CN¥872.61 Million ≈ $127.69 Million	CN¥-20.88 Million ≈ $-3.05 Million	-0.024x	-132.04%
2019-12-31	CN¥932.60 Million ≈ $136.47 Million	CN¥69.63 Million ≈ $10.19 Million	0.075x	+80.88%
2018-12-31	CN¥931.24 Million ≈ $136.27 Million	CN¥38.44 Million ≈ $5.63 Million	0.041x	-0.04%
2017-12-31	CN¥971.17 Million ≈ $142.11 Million	CN¥40.10 Million ≈ $5.87 Million	0.041x	-5.33%
2016-12-31	CN¥954.85 Million ≈ $139.72 Million	CN¥41.65 Million ≈ $6.09 Million	0.044x	+146.44%
2015-12-31	CN¥872.50 Million ≈ $127.67 Million	CN¥15.44 Million ≈ $2.26 Million	0.018x	-82.27%
2014-12-31	CN¥823.16 Million ≈ $120.45 Million	CN¥82.19 Million ≈ $12.03 Million	0.100x	-4.94%
2013-12-31	CN¥767.16 Million ≈ $112.26 Million	CN¥80.58 Million ≈ $11.79 Million	0.105x	+95.14%
2012-12-31	CN¥651.17 Million ≈ $95.29 Million	CN¥35.05 Million ≈ $5.13 Million	0.054x	+558.60%
2011-12-31	CN¥581.17 Million ≈ $85.04 Million	CN¥4.75 Million ≈ $695.08K	0.008x	-97.65%
2010-12-31	CN¥149.59 Million ≈ $21.89 Million	CN¥52.03 Million ≈ $7.61 Million	0.348x	-61.24%
2009-12-31	CN¥117.60 Million ≈ $17.21 Million	CN¥105.55 Million ≈ $15.45 Million	0.898x	+344.54%
2008-12-31	CN¥106.70 Million ≈ $15.61 Million	CN¥-39.16 Million ≈ $-5.73 Million	-0.367x	--

About Shanxi C&Y Pharmaceutical Group Co Ltd

SHE:300254 China Drug Manufacturers - Specialty & Generic

Market Cap

$505.94 Million

CN¥3.46 Billion CNY

Market Cap Rank

#12476 Global

#3879 in China

Share Price

CN¥13.50

Change (1 day)

+5.39%

52-Week Range

CN¥9.03 - CN¥13.60

All Time High

CN¥31.09